↓ Skip to main content

Annonaceae: Breaking the Wall of Inflammation

Overview of attention for article published in Frontiers in Pharmacology, October 2017
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
35 Dimensions

Readers on

mendeley
144 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Annonaceae: Breaking the Wall of Inflammation
Published in
Frontiers in Pharmacology, October 2017
DOI 10.3389/fphar.2017.00752
Pubmed ID
Authors

Ali Attiq, Juriyati Jalil, Khairana Husain

Abstract

Inventories of tropical forests have listed Annonaceae as one of the most diverse plant families. For centuries, it is employed in traditional medicines to cure various pathological conditions including snakebite, analgesic, astringent, diarrhea, dysentery, arthritis pain, rheumatism, neuralgia, and weight loss etc. Phytochemical analysis of Annonaceae family have reported the occurrence of alkaloids, flavonoids, triterpenes, diterpenes and diterpene flavone glycosides, sterols, lignans, and annonaceous acetogenin characteristically affiliated with Annonaceae sp. Numerous past studies have underlined the pleotropic pharmacological activities of the crude extracts and isolated compounds from Annonaceae species. This review is an effort to abridge the ethnobotany, morphology, phytochemistry, toxicity, and particularly focusing on the anti-inflammatory activity of the Annonaceae species.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 144 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 144 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 25 17%
Student > Master 14 10%
Student > Ph. D. Student 10 7%
Student > Doctoral Student 8 6%
Researcher 8 6%
Other 15 10%
Unknown 64 44%
Readers by discipline Count As %
Chemistry 21 15%
Agricultural and Biological Sciences 13 9%
Pharmacology, Toxicology and Pharmaceutical Science 10 7%
Biochemistry, Genetics and Molecular Biology 9 6%
Medicine and Dentistry 8 6%
Other 11 8%
Unknown 72 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 November 2017.
All research outputs
#18,574,814
of 23,006,268 outputs
Outputs from Frontiers in Pharmacology
#8,363
of 16,313 outputs
Outputs of similar age
#251,817
of 328,577 outputs
Outputs of similar age from Frontiers in Pharmacology
#141
of 290 outputs
Altmetric has tracked 23,006,268 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 16,313 research outputs from this source. They receive a mean Attention Score of 5.0. This one is in the 37th percentile – i.e., 37% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 328,577 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 290 others from the same source and published within six weeks on either side of this one. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.